Novavax Inc. (nvax 5 12/15/27)
13F holders, Q2 2025 (June 30)1holders
1new positions
0sold out
$1.01avg. 13F price*
At the end of Q2 2025, 1 institutions reported holding Novavax Inc. (nvax 5 12/15/27) in their 13F filings, unchanged from Q2 2024. 1 opened new positions and 0 sold out. The largest holder was Graham Capital Management, L.P. ($74.8M).
- Company
- Novavax Inc. (nvax 5 12/15/27)
- CUSIP
- 670002AD6
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $74.8M |
| Exits | 0 | $0 |
All 13F filers, Q2 2024 → Q2 2025: 74,177,000 shares bought, net +74,177,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Graham Capital Management, L.P. | 2.28% | New | 74,177,000 | $74.8M |
"% of holder's portfolio" is NOVAVAX INC (NVAX 5 12/15/27)'s weight in each manager's 13F, not the share of Novavax Inc. (nvax 5 12/15/27) the manager owns.